pre-miRNA Information
pre-miRNA hsa-mir-628   
Genomic Coordinates chr15: 55372940 - 55373034
Synonyms MIRN628, hsa-mir-628, MIR628
Description Homo sapiens miR-628 stem-loop
Comment The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-628-3p
Sequence 61| UCUAGUAAGAGUGGCAGUCGA |81
Evidence Experimental
Experiments Microarray
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 7 15 - 55372968 29233923 MiREDiBase
A-to-I 8 15 - 55372967 29233923 MiREDiBase
C-to-U 19 15 - 55372956 20591823 MiREDiBase
DRVs in miRNA
Mutant ID Mutant Position Mutant Source
COSN26969715 1 COSMIC
COSN30123186 10 COSMIC
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1410255602 2 dbSNP
rs1401315366 3 dbSNP
rs1322836365 4 dbSNP
rs1158103480 8 dbSNP
rs1216611749 11 dbSNP
rs749619551 13 dbSNP
rs778157225 18 dbSNP
rs756600789 19 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol REPIN1   
Synonyms AP4, RIP60, ZNF464, Zfp464
Description replication initiator 1
Transcript NM_001099695   
Other Transcripts NM_001099696 , NM_013400 , NM_014374   
Expression
Putative miRNA Targets on REPIN1
3'UTR of REPIN1
(miRNA target sites are highlighted)
>REPIN1|NM_001099695|3'UTR
   1 GACGGTGGGCGGGGCCGTGTTGGCTGAGAGAGGGCTGGGGTCCTTCGTGGTGGGAGTCGCAGTGGGCTGGGGGTGCCTGC
  81 CTAGTGCTGGAGTAGGGGACAATGGGAATCCTAGAGGGGATGGAAGACGCGGGGAGTGAGCTGGGTGGGCCCTGCTAGCG
 161 AGAGAGGTCAACCCCGGTGGCCAGGGAACCCACTTCCAAGCGCAGGGACGCCGGCCTCCAGCTGGTGTGTGCTAAGGCTC
 241 CGTCCTGACTGCCCTGTGCCCTGGAAAAGCAGCAATAGCATCCGCCCCTTAGAGCCCTCTGGCTAGAGGAGCCACCAGTG
 321 GAAAGGAAGACCCTCCATCCTCTGGTATTAACGCCTTAATGCCCCTGTCTTTTACTGTAAGTTACTTAAGATCATTTTTG
 401 GAAGCAGGCGTGGTAGAGTCCTGTAAATGAATGCTCTGGGCTAGATACAGCTTGGAGAACCTGCTGGCCTTGTTAGACAG
 481 CACTTGGGCCTTTGCCAGCAGCAAGAGGTGAAGCGAAGCCACTCTTACCTCTCCCTTCCCCTCCCACCTGCCCCCTGCGT
 561 AGGCACCCAGACTTGGAGAGACCCGTCTGCTGTTAATACTTCCATCCTCTTCCTTCCCAAAGAGCAGATCCCAAGGCATT
 641 TACTCCTTGGTCTGTCTCGCTTTATCTGTCGCCCCTCCCAGCGCTGAGAGCCTCCCCTGGCTGTCAGCAGCACTGTGTCC
 721 AGGCTCTTGTCTGAACACCGCAGCCCCTCCTTCGCTCCTTCCAGAGCTCAGCATGTCACGGCAAGGACTGCCGCATTGGT
 801 GATGGAGGGCCAGCTGAGGGGAAGTTGCTGGTGAGTTTCCTTTTCTCCATTTCTAGCATATGGACACCTGGCCTCTGCTT
 881 GAGCACTTAGGTGACAGGAACTTCCGCACCTCCTGAGGCCCTGGATGATTCTAATTGTTAGAAATTCTAATTGTTAGAAA
 961 TCCTTCCTTATAATGAATGAATTCTGCTTTCCTATAATTTCTACCTATTGGGCCTTGTTCTGTTCTCTGGAACTAAACAG
1041 AACAACCATTTACCCCTCCTTTTCAAACTAGAGAATAAAGATTTGGTTTTAGAACTGGTAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' agcuGACGGUGAGAAUGAUCu 5'
              ||||::  |||::||| 
Target 5' gaacCTGCTGGCCTTGTTAGa 3'
457 - 477 129.00 -12.90
2
miRNA  3' agcuGACGGUGAGAAUGAUcu 5'
              |||:  ||:|||||:  
Target 5' gcccCTGT--CTTTTACTGta 3'
361 - 379 121.00 -9.10
3
miRNA  3' agcUGACGG----UGAG---AAUGAUCu 5'
             |:||::    |:||   ||::||| 
Target 5' ctaATTGTTAGAAATTCTAATTGTTAGa 3'
931 - 958 116.00 -8.10
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN5853211 4 COSMIC
COSN30150870 5 COSMIC
COSN30478190 5 COSMIC
COSN31511209 11 COSMIC
COSN30501397 21 COSMIC
COSN30479150 27 COSMIC
COSN30518414 27 COSMIC
COSN19212826 59 COSMIC
COSN30108764 79 COSMIC
COSN15626115 111 COSMIC
COSN30510479 120 COSMIC
COSN31590436 130 COSMIC
COSN30133861 132 COSMIC
COSN31550540 145 COSMIC
COSN31778617 157 COSMIC
COSN31595313 181 COSMIC
COSN26556287 187 COSMIC
COSN31589541 202 COSMIC
COSN31542709 203 COSMIC
COSN22165177 241 COSMIC
COSN21701199 242 COSMIC
COSN25145949 264 COSMIC
COSN5651723 367 COSMIC
COSN30143484 421 COSMIC
COSN30529793 427 COSMIC
COSN30143121 490 COSMIC
COSN30510069 507 COSMIC
COSN21765485 552 COSMIC
COSN28741561 597 COSMIC
COSN28821792 630 COSMIC
COSN30531795 652 COSMIC
COSN30544093 772 COSMIC
COSN28821203 781 COSMIC
COSN31482096 783 COSMIC
COSN26552047 794 COSMIC
COSN30530678 820 COSMIC
COSN24302132 857 COSMIC
COSN30136282 962 COSMIC
COSN30112341 980 COSMIC
COSN9936614 1005 COSMIC
COSN31490790 1044 COSMIC
COSN31596646 1088 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1380067767 2 dbSNP
rs765174380 4 dbSNP
rs752590604 7 dbSNP
rs761921076 12 dbSNP
rs1281708597 15 dbSNP
rs767610161 18 dbSNP
rs1311996985 21 dbSNP
rs1239981165 26 dbSNP
rs1262753903 27 dbSNP
rs1484919365 31 dbSNP
rs1216054389 33 dbSNP
rs750666548 34 dbSNP
rs1420544708 37 dbSNP
rs1490474675 39 dbSNP
rs1201523129 42 dbSNP
rs1264946095 44 dbSNP
rs756351072 45 dbSNP
rs1023759899 50 dbSNP
rs1159340452 51 dbSNP
rs1181595883 54 dbSNP
rs1487192675 59 dbSNP
rs1471676696 62 dbSNP
rs1234512847 69 dbSNP
rs551774111 72 dbSNP
rs568786439 74 dbSNP
rs907499331 75 dbSNP
rs1212425220 102 dbSNP
rs116293076 103 dbSNP
rs554480290 111 dbSNP
rs73474368 112 dbSNP
rs534041526 118 dbSNP
rs1215108791 119 dbSNP
rs899106310 121 dbSNP
rs183206903 123 dbSNP
rs1226005755 124 dbSNP
rs961330211 126 dbSNP
rs1417727264 128 dbSNP
rs972941907 131 dbSNP
rs573297366 136 dbSNP
rs919762643 137 dbSNP
rs890324662 139 dbSNP
rs780101097 142 dbSNP
rs545392240 149 dbSNP
rs558970006 150 dbSNP
rs1324326298 151 dbSNP
rs1463176523 168 dbSNP
rs1395461565 170 dbSNP
rs1428171894 172 dbSNP
rs1165685602 174 dbSNP
rs575742388 182 dbSNP
rs1459912379 184 dbSNP
rs761453488 184 dbSNP
rs1008943576 185 dbSNP
rs910998536 186 dbSNP
rs1177643973 189 dbSNP
rs1325215966 190 dbSNP
rs1389270645 195 dbSNP
rs1477662385 196 dbSNP
rs1257083266 203 dbSNP
rs1031511932 204 dbSNP
rs1437117507 210 dbSNP
rs956703349 213 dbSNP
rs1195300257 218 dbSNP
rs1360965119 222 dbSNP
rs377426608 233 dbSNP
rs1314411084 250 dbSNP
rs1040729694 254 dbSNP
rs1332088728 259 dbSNP
rs561612183 262 dbSNP
rs969613960 265 dbSNP
rs530186400 267 dbSNP
rs1284364061 268 dbSNP
rs928116765 276 dbSNP
rs1054487905 284 dbSNP
rs1301940154 287 dbSNP
rs188141580 300 dbSNP
rs948233277 302 dbSNP
rs191964359 303 dbSNP
rs1320140998 305 dbSNP
rs907630653 306 dbSNP
rs1346977183 319 dbSNP
rs1159948686 320 dbSNP
rs1413794891 336 dbSNP
rs1393158974 337 dbSNP
rs879228245 346 dbSNP
rs1211078840 350 dbSNP
rs940345152 351 dbSNP
rs1485732666 356 dbSNP
rs1184346501 365 dbSNP
rs1182702009 366 dbSNP
rs1486656625 394 dbSNP
rs1242150813 401 dbSNP
rs1037312295 406 dbSNP
rs906632885 411 dbSNP
rs3192130 413 dbSNP
rs1237234305 417 dbSNP
rs1348962012 427 dbSNP
rs931895699 446 dbSNP
rs551884072 447 dbSNP
rs1164320716 448 dbSNP
rs1364383883 450 dbSNP
rs1014932531 451 dbSNP
rs1289709731 473 dbSNP
rs1447359580 478 dbSNP
rs768516226 482 dbSNP
rs1458784116 483 dbSNP
rs1314639625 490 dbSNP
rs897021870 503 dbSNP
rs1156782072 506 dbSNP
rs1344442902 515 dbSNP
rs994095840 516 dbSNP
rs774189227 526 dbSNP
rs1168096957 527 dbSNP
rs1448446831 529 dbSNP
rs1304300766 530 dbSNP
rs1353189819 533 dbSNP
rs375821873 533 dbSNP
rs890260300 536 dbSNP
rs1009160412 541 dbSNP
rs1052503991 545 dbSNP
rs1486296627 552 dbSNP
rs568498431 553 dbSNP
rs1288459617 560 dbSNP
rs1026891602 561 dbSNP
rs952533991 562 dbSNP
rs1309682645 567 dbSNP
rs1296544685 574 dbSNP
rs892525096 575 dbSNP
rs761570199 583 dbSNP
rs1353568209 586 dbSNP
rs1330542541 588 dbSNP
rs1051760 597 dbSNP
rs1051764 630 dbSNP
rs1316765242 632 dbSNP
rs1369841624 639 dbSNP
rs969418059 650 dbSNP
rs1463322931 655 dbSNP
rs965167043 656 dbSNP
rs184568102 665 dbSNP
rs960879533 669 dbSNP
rs1419323594 670 dbSNP
rs760702502 671 dbSNP
rs1471999755 672 dbSNP
rs1250404223 680 dbSNP
rs1481821246 681 dbSNP
rs983373547 684 dbSNP
rs923628099 691 dbSNP
rs908734597 703 dbSNP
rs935027674 708 dbSNP
rs1333005743 715 dbSNP
rs989737453 723 dbSNP
rs1233954753 729 dbSNP
rs973162033 731 dbSNP
rs1350017567 735 dbSNP
rs533709234 740 dbSNP
rs915521351 742 dbSNP
rs553953335 746 dbSNP
rs948178014 754 dbSNP
rs1473594403 755 dbSNP
rs1045270143 756 dbSNP
rs1396178816 757 dbSNP
rs985981669 765 dbSNP
rs911816497 769 dbSNP
rs906580272 774 dbSNP
rs1361628207 780 dbSNP
rs1051823 781 dbSNP
rs568607326 794 dbSNP
rs1251640199 796 dbSNP
rs543350624 806 dbSNP
rs1467455888 808 dbSNP
rs1255110917 810 dbSNP
rs1177986685 811 dbSNP
rs995275225 820 dbSNP
rs753150848 821 dbSNP
rs758877529 822 dbSNP
rs946779412 840 dbSNP
rs1302629599 845 dbSNP
rs1438410413 848 dbSNP
rs1372984773 853 dbSNP
rs1043837892 859 dbSNP
rs753749104 861 dbSNP
rs1433911174 865 dbSNP
rs752672882 877 dbSNP
rs1351854493 890 dbSNP
rs536005303 895 dbSNP
rs1159828677 904 dbSNP
rs559132783 905 dbSNP
rs1364859501 906 dbSNP
rs1018066578 919 dbSNP
rs1173626828 927 dbSNP
rs1278363823 928 dbSNP
rs371626146 928 dbSNP
rs965628555 933 dbSNP
rs575704271 936 dbSNP
rs1446664256 937 dbSNP
rs760061449 950 dbSNP
rs1259691673 964 dbSNP
rs1206936054 968 dbSNP
rs976523529 971 dbSNP
rs1373253305 972 dbSNP
rs1220260184 984 dbSNP
rs1349696006 987 dbSNP
rs765732778 993 dbSNP
rs189325156 998 dbSNP
rs1324290013 1001 dbSNP
rs1319936753 1003 dbSNP
rs1346117575 1005 dbSNP
rs956382460 1007 dbSNP
rs1004498391 1009 dbSNP
rs14356 1014 dbSNP
rs1275590409 1015 dbSNP
rs11764897 1029 dbSNP
rs575090642 1035 dbSNP
rs540446106 1041 dbSNP
rs192583157 1049 dbSNP
rs115575718 1052 dbSNP
rs1377605927 1054 dbSNP
rs1232321610 1059 dbSNP
rs1174686578 1068 dbSNP
rs1475312693 1071 dbSNP
rs948291741 1082 dbSNP
rs980894583 1083 dbSNP
rs928148818 1087 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' agcugacGGUGAGAAUGaucu 5'
                 ||||||||||    
Target 5' -------CCACUCUUACcucu 3'
1 - 14
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM1462574
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl ami BaL
Location of target site ENST00000479668.1 | 3UTR | CCACUCUUACCUCUCCCUUCCCCUCCCACCUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
GSE27834 Pluripotent stem cells 0.726 7.3e-4 0.715 9.3e-4 16 Click to see details
GSE28544 Breast cancer 0.611 7.6e-4 0.585 1.3e-3 24 Click to see details
GSE34608 Pulmonary tuberculosis and sarcoidosis -0.511 1.1e-2 -0.538 7.2e-3 20 Click to see details
GSE38974 Chronic obstructive pulmonary disease 0.38 3.0e-2 0.460 1.0e-2 25 Click to see details
GSE14794 Lymphoblastoid cells 0.194 3.3e-2 0.221 1.8e-2 90 Click to see details
GSE17498 Multiple myeloma -0.243 6.5e-2 -0.276 4.2e-2 40 Click to see details
GSE42095 Differentiated embryonic stem cells 0.304 7.9e-2 0.240 1.4e-1 23 Click to see details
GSE21849 B cell lymphoma 0.266 8.2e-2 0.536 1.4e-3 29 Click to see details
GSE19783 ER- ER- breast cancer 0.153 8.9e-2 0.196 4.2e-2 79 Click to see details
GSE19536 Breast cancer 0.115 1.3e-1 0.155 6.2e-2 100 Click to see details
GSE26953 Aortic valvular endothelial cells -0.209 1.6e-1 -0.258 1.1e-1 24 Click to see details
GSE32688 Pancreatic cancer -0.157 2.0e-1 -0.036 4.2e-1 32 Click to see details
GSE17306 Multiple myeloma 0.092 2.6e-1 0.140 1.7e-1 49 Click to see details
GSE19783 ER+ ER+ breast cancer 0.114 3.2e-1 0.035 4.4e-1 20 Click to see details
GSE19350 CNS germ cell tumors 0.145 3.3e-1 0.098 3.8e-1 12 Click to see details
GSE38226 Liver fibrosis -0.087 3.5e-1 -0.121 3.0e-1 21 Click to see details
GSE28260 Renal cortex and medulla -0.048 4.4e-1 -0.132 3.3e-1 13 Click to see details
GSE21687 Ependynoma primary tumors -0.008 4.7e-1 -0.019 4.4e-1 64 Click to see details
GSE21687 Ependynoma primary tumors -0.008 4.7e-1 -0.019 4.4e-1 64 Click to see details
GSE21687 Ependynoma primary tumors -0.008 4.7e-1 -0.019 4.4e-1 64 Click to see details
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
BRCA 0.293 0.05 0.245 0.08 34 Click to see details
KICH -0.294 0.09 -0.315 0.08 22 Click to see details
THCA -0.173 0.1 -0.168 0.1 58 Click to see details
PCPG -0.926 0.12 -1.000 0.5 3 Click to see details
KIRP 0.159 0.21 0.095 0.31 29 Click to see details
PAAD -0.576 0.21 -0.800 0.1 4 Click to see details
LUSC 0.117 0.25 0.257 0.07 35 Click to see details
BLCA -0.174 0.25 -0.191 0.23 17 Click to see details
ESCA 0.224 0.25 0.173 0.31 11 Click to see details
PRAD 0.109 0.26 0.064 0.36 36 Click to see details
CHOL 0.239 0.3 0.143 0.38 7 Click to see details
CESC 0.58 0.3 0.500 0.33 3 Click to see details
UCEC 0.111 0.33 0.104 0.34 18 Click to see details
LUAD 0.118 0.37 -0.030 0.47 10 Click to see details
LIHC -0.018 0.45 0.019 0.45 49 Click to see details
STAD -0.007 0.49 -0.044 0.41 28 Click to see details
HNSC 0.005 0.49 0.013 0.47 35 Click to see details
KIRC -0.003 0.49 -0.034 0.42 40 Click to see details
KIRC -0.003 0.49 -0.034 0.42 40 Click to see details
27 hsa-miR-628-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT039584 CDC14A cell division cycle 14A 1 1
MIRT039585 AGO1 argonaute 1, RISC catalytic component 2 3
MIRT039586 TGFBRAP1 transforming growth factor beta receptor associated protein 1 1 1
MIRT039587 LRP6 LDL receptor related protein 6 1 1
MIRT071876 BTF3L4 basic transcription factor 3 like 4 2 2
MIRT097443 JMY junction mediating and regulatory protein, p53 cofactor 2 4
MIRT100100 ABT1 activator of basal transcription 1 2 8
MIRT147692 CBX4 chromobox 4 2 2
MIRT408248 PURA purine rich element binding protein A 2 2
MIRT442047 LRAT lecithin retinol acyltransferase 2 2
MIRT444412 RAB3IP RAB3A interacting protein 2 2
MIRT452599 REPIN1 replication initiator 1 2 2
MIRT469515 RBFOX2 RNA binding protein, fox-1 homolog 2 2 8
MIRT498192 AKR1B10 aldo-keto reductase family 1 member B10 2 2
MIRT500151 CREBBP CREB binding protein 2 2
MIRT507319 FAM60A SIN3-HDAC complex associated factor 2 6
MIRT508343 ZNF273 zinc finger protein 273 2 6
MIRT520480 TRIM13 tripartite motif containing 13 2 2
MIRT522461 MMP16 matrix metallopeptidase 16 2 4
MIRT547116 PHLPP2 PH domain and leucine rich repeat protein phosphatase 2 2 2
MIRT548675 CRNKL1 crooked neck pre-mRNA splicing factor 1 2 2
MIRT553756 TARBP2 TARBP2, RISC loading complex RNA binding subunit 2 4
MIRT559437 ARSJ arylsulfatase family member J 2 2
MIRT610490 GPC4 glypican 4 2 2
MIRT644682 TMCO1 transmembrane and coiled-coil domains 1 2 2
MIRT658214 FBXO21 F-box protein 21 2 2
MIRT756083 TP53 tumor protein p53 4 1
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-628 Cisplatin 5460033 NSC119875 approved sensitive cell line (BxPC3)
hsa-miR-628-3p Cisplatin 5460033 NSC119875 approved resistant High Tongue Squamous Cell Carcinoma cell line (Tca8113)
hsa-miR-628-3p Tamoxifen 2733525 NSC180973 approved resistant High Breast Cancer cell line (MCF-7, LY2)
hsa-miR-628-3p Erlotinib 176870 NSC718781 approved sensitive High Epithelial Cancer cell line (A549, UKY-29, H460, H1975, H1650, H3255, PC-9, H358)
hsa-miR-628-3p Siop Treatment Protocol sensitive High Nephroblastoma tissue
hsa-miR-628-3p Sunitinib 5329102 NSC750690 approved resistant High Metastatic Renal Cell Carcinoma tissue and cell line (Caki-2)
hsa-miR-628-3p Chemotherapy sensitive High Epithelial Ovarian Cancer tissue
hsa-miR-628-3p Platinum-based doublet chemotherapy resistant Low Lung Adenocarcinoma tissue
hsa-miR-628-3p Doxorubicin 31703 NSC123127 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-628-3p Tamoxifen 2733525 NSC180973 approved resistant High Breast Cancer cell line (TAMR8)
hsa-miR-628-3p Aromatase Inhibitor sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-628-3p Dabrafenib 44462760 NSC764134 approved resistant High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-628-3p Vemurafenib 42611257 NSC761431 approved resistant High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-628-3p Ceritinib 57379345 NSC776422 approved sensitive High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-628-3p Platinum 23939 sensitive High High-Grade Serous Ovarian Cancer tissue
hsa-miR-628-3p Cisplatin 5460033 NSC119875 approved sensitive High Bladder Cancer cell line (CDDP-R-BOY, CDDP-R-T24)
hsa-miR-628-3p Gefitinib 123631 NSC715055 approved resistant cell line (HCC827)
hsa-miR-628-3p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-628-3p Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-miR-628-3p Sunitinib 5329102 NSC750690 approved resistant tissue (CardB)
hsa-miR-628-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR8)
hsa-miR-628-3p Oxaliplatin 6857599 NSC266046 approved sensitive cell line (IGROV-1)
hsa-miR-628-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-628-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-628-3p Docetaxel+Cisplatin+5-Fluorouracil sensitive tissue (hypopharyngeal squamous cell carcinoma)

Error report submission